367 related articles for article (PubMed ID: 34272325)
21. PET Imaging of Fibroblast Activation Protein in Various Types of Cancer Using
Pang Y; Zhao L; Meng T; Xu W; Lin Q; Wu H; Zhang J; Chen X; Sun L; Chen H
J Nucl Med; 2023 Mar; 64(3):386-394. PubMed ID: 36215571
[TBL] [Abstract][Full Text] [Related]
22. [
Rosenkrans ZT; Massey CF; Bernau K; Ferreira CA; Jeffery JJ; Schulte JJ; Moore M; Valla F; Batterton JM; Drake CR; McMillan AB; Sandbo N; Pirasteh A; Hernandez R
Eur J Nucl Med Mol Imaging; 2022 Sep; 49(11):3705-3716. PubMed ID: 35556159
[TBL] [Abstract][Full Text] [Related]
23.
Kratochwil C; Flechsig P; Lindner T; Abderrahim L; Altmann A; Mier W; Adeberg S; Rathke H; Röhrich M; Winter H; Plinkert PK; Marme F; Lang M; Kauczor HU; Jäger D; Debus J; Haberkorn U; Giesel FL
J Nucl Med; 2019 Jun; 60(6):801-805. PubMed ID: 30954939
[TBL] [Abstract][Full Text] [Related]
24.
Chen L; Zheng S; Chen L; Xu S; Wu K; Kong L; Xue J; Chen X; Miao W; Zhu Y
J Nucl Med; 2023 Dec; 64(12):1899-1905. PubMed ID: 37918866
[No Abstract] [Full Text] [Related]
25.
Bergmann C; Distler JHW; Treutlein C; Tascilar K; Müller AT; Atzinger A; Matei AE; Knitza J; Györfi AH; Lück A; Dees C; Soare A; Ramming A; Schönau V; Distler O; Prante O; Ritt P; Götz TI; Köhner M; Cordes M; Bäuerle T; Kuwert T; Schett G; Schmidkonz C
Lancet Rheumatol; 2021 Mar; 3(3):e185-e194. PubMed ID: 38279381
[TBL] [Abstract][Full Text] [Related]
26. [
Ji H; Song X; Lv X; Shao F; Long Y; Song Y; Song W; Qiao P; Gai Y; Jiang D; Lan X
Pharmaceuticals (Basel); 2024 Jun; 17(6):. PubMed ID: 38931393
[TBL] [Abstract][Full Text] [Related]
27. Synthesis, Preclinical Evaluation, and a Pilot Clinical PET Imaging Study of
Zhao L; Niu B; Fang J; Pang Y; Li S; Xie C; Sun L; Zhang X; Guo Z; Lin Q; Chen H
J Nucl Med; 2022 Jun; 63(6):862-868. PubMed ID: 34556528
[TBL] [Abstract][Full Text] [Related]
28. Usefulness of [
Li C; Tian Y; Chen J; Jiang Y; Xue Z; Xing D; Wen B; He Y
Eur Radiol; 2023 Apr; 33(4):2779-2791. PubMed ID: 36394603
[TBL] [Abstract][Full Text] [Related]
29.
Wang H; Zhu W; Ren S; Kong Y; Huang Q; Zhao J; Guan Y; Jia H; Chen J; Lu L; Xie F; Qin L
Front Oncol; 2021; 11():693640. PubMed ID: 34249748
[TBL] [Abstract][Full Text] [Related]
30. Comparison of
Wang L; Tang G; Hu K; Liu X; Zhou W; Li H; Huang S; Han Y; Chen L; Zhong J; Wu H
Radiology; 2022 Apr; 303(1):191-199. PubMed ID: 34981976
[TBL] [Abstract][Full Text] [Related]
31. Fibroblast imaging of hepatic carcinoma with
Shi X; Xing H; Yang X; Li F; Yao S; Zhang H; Zhao H; Hacker M; Huo L; Li X
Eur J Nucl Med Mol Imaging; 2021 Jan; 48(1):196-203. PubMed ID: 32468254
[TBL] [Abstract][Full Text] [Related]
32. Molecular Imaging of Fibroblast Activity After Myocardial Infarction Using a
Varasteh Z; Mohanta S; Robu S; Braeuer M; Li Y; Omidvari N; Topping G; Sun T; Nekolla SG; Richter A; Weber C; Habenicht A; Haberkorn UA; Weber WA
J Nucl Med; 2019 Dec; 60(12):1743-1749. PubMed ID: 31405922
[TBL] [Abstract][Full Text] [Related]
33. [
Hu K; Wang L; Wu H; Huang S; Tian Y; Wang Q; Xiao C; Han Y; Tang G
Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2833-2843. PubMed ID: 34893920
[TBL] [Abstract][Full Text] [Related]
34.
Liu Y; Zhang Q; Zhang Y; Wang J; Wu Y; Yang G; Shi J; Wang F; Xu Z; Jing H
Pharmaceuticals (Basel); 2023 Oct; 16(10):. PubMed ID: 37895905
[TBL] [Abstract][Full Text] [Related]
35. Head-to-Head Comparison of [
Wegen S; van Heek L; Linde P; Claus K; Akuamoa-Boateng D; Baues C; Sharma SJ; Schomäcker K; Fischer T; Roth KS; Klußmann JP; Marnitz S; Drzezga A; Kobe C
Mol Imaging Biol; 2022 Dec; 24(6):986-994. PubMed ID: 35771317
[TBL] [Abstract][Full Text] [Related]
36. Three-Time-Point PET Analysis of
Naeimi M; Choyke PL; Dendl K; Mori Y; Staudinger F; Watabe T; Koerber SA; Röhrich M; Debus J; Kratochwil C; Haberkorn U; Giesel FL
J Nucl Med; 2023 Apr; 64(4):618-622. PubMed ID: 36357183
[TBL] [Abstract][Full Text] [Related]
37. Comparison of early and late
Hoppner J; van Genabith L; Hielscher T; Heger U; Sperling L; Colbatzky T; Gutjahr E; Lang M; Pausch T; Spektor AM; Glatting FM; Liermann J; Hackert T; Kratochwil C; Giesel FL; Haberkorn U; Röhrich M
Sci Rep; 2023 Oct; 13(1):17848. PubMed ID: 37857656
[TBL] [Abstract][Full Text] [Related]
38. Feasibility of acquisitions using total-body PET/CT with a half-dose [
Chen Z; Wang Y; Yang X; Li L; Huo Y; Yu X; Xiao X; Zhang C; Chen Y; Zhao H; Zhou Y; Huang G; Liu J; Chen R
Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):3961-3969. PubMed ID: 37535107
[TBL] [Abstract][Full Text] [Related]
39. Novel FAP ligands enable improved imaging contrast in sarcoma patients due to FAPI-PET/CT.
Koerber SA; Finck R; Dendl K; Uhl M; Lindner T; Kratochwil C; Röhrich M; Rathke H; Ungerechts G; Adeberg S; Herfarth K; Jaeger D; Debus J; Haberkorn U; Giesel FL
Eur J Nucl Med Mol Imaging; 2021 Nov; 48(12):3918-3924. PubMed ID: 34018010
[TBL] [Abstract][Full Text] [Related]
40. Head-to-head intra-individual comparison of biodistribution and tumor uptake of
Giesel FL; Kratochwil C; Schlittenhardt J; Dendl K; Eiber M; Staudinger F; Kessler L; Fendler WP; Lindner T; Koerber SA; Cardinale J; Sennung D; Roehrich M; Debus J; Sathekge M; Haberkorn U; Calais J; Serfling S; Buck AL
Eur J Nucl Med Mol Imaging; 2021 Dec; 48(13):4377-4385. PubMed ID: 34137945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
